🇺🇸 FDA
Patent

US 7105560

Use of etodolac in the treatment of multiple myeloma

granted A61KA61K31/198A61K31/407

Quick answer

US patent 7105560 (Use of etodolac in the treatment of multiple myeloma) held by The Regents of the University of California expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/198, A61K31/407, A61K45/06, A61P